IRADIMED CORPORATION Announces First Quarter 2019 Financial Results
30 avr. 2019 07h00 HE
|
iRadimed Corporation
Reports first quarter 2019 revenue of $8.4 millionReports first quarter 2019 GAAP diluted EPS of $0.15 and non-GAAP diluted EPS of $0.13 WINTER SPRINGS, Fla., April 30, 2019 (GLOBE NEWSWIRE) --...
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results Conference Call on April 30th
16 avr. 2019 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market...
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor
02 avr. 2019 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”)...
IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results
06 févr. 2019 07h00 HE
|
iRadimed Corporation
Reports fourth quarter 2018 revenue of $8.3 millionReports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.16Announces 2019 full year and first quarter financial...
IRADIMED CORPORATION to Hold 2018 Fourth Quarter Financial Results Conference Call on February 6th
22 janv. 2019 07h10 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2018 fourth quarter financial results before the market...
IRADIMED CORPORATION Expects Minor Impact to 2019 Revenue After Temporarily Suspending Shipments of MRI Compatible Patient Vital Signs Monitoring Systems in European Markets
22 janv. 2019 07h00 HE
|
iRadimed Corporation
Action being taken after CE mark expirationExpects negative impact to full-year 2019 revenue of approximately two percent WINTER SPRINGS, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- IRADIMED...
IRADIMED CORPORATION Announces 510(k) Clearance of Invasive Blood Pressure Module for use with its MRI-Compatible Patient Vital Signs Monitor
19 déc. 2018 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today...
IRADIMED CORPORATION Announces Third Quarter 2018 Financial Results
30 oct. 2018 07h00 HE
|
iRadimed Corporation
Reports third quarter 2018 revenue of $7.6 millionReports third quarter 2018 GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.14Increases full year 2018 revenue, GAAP and non-GAAP diluted...
IRADIMED CORPORATION to Hold 2018 Third Quarter Financial Results Conference Call on October 30th
16 oct. 2018 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 third quarter financial results before the market...
IRADIMED CORPORATION Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan
11 sept. 2018 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Sept. 11, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today...